Ott Laius

2.3k total citations
23 papers, 396 citations indexed

About

Ott Laius is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Economics and Econometrics. According to data from OpenAlex, Ott Laius has authored 23 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Public Health, Environmental and Occupational Health, 6 papers in Pediatrics, Perinatology and Child Health and 6 papers in Economics and Econometrics. Recurrent topics in Ott Laius's work include Health Systems, Economic Evaluations, Quality of Life (6 papers), Medication Adherence and Compliance (4 papers) and Bone health and osteoporosis research (4 papers). Ott Laius is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (6 papers), Medication Adherence and Compliance (4 papers) and Bone health and osteoporosis research (4 papers). Ott Laius collaborates with scholars based in Estonia, Finland and Spain. Ott Laius's co-authors include Lars L. Gustafsson, Brian Godman, Catherine Sermet, Kristina Garuolienė, Marija Kalaba, Corrine Zara, Harald Herholz, Alan Haycox, Silvio Garattini and Saira Jan and has published in prestigious journals such as Journal of Medical Internet Research, Experimental Biology and Medicine and BMC Health Services Research.

In The Last Decade

Ott Laius

20 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ott Laius Estonia 7 292 86 69 40 32 23 396
Roberta Joppi Italy 10 326 1.1× 101 1.2× 59 0.9× 44 1.1× 21 0.7× 20 451
Lisa A. Fulchino United States 8 160 0.5× 68 0.8× 46 0.7× 23 0.6× 21 0.7× 11 307
Genia Long United States 9 294 1.0× 56 0.7× 50 0.7× 37 0.9× 93 2.9× 19 391
Marija Kalaba Sweden 8 269 0.9× 62 0.7× 64 0.9× 11 0.3× 36 1.1× 10 418
Niesha Griffith United States 10 117 0.4× 138 1.6× 27 0.4× 40 1.0× 36 1.1× 21 402
Karen Van Nuys United States 10 128 0.4× 41 0.5× 26 0.4× 45 1.1× 33 1.0× 24 590
Harald Herholz Germany 7 210 0.7× 32 0.4× 41 0.6× 31 0.8× 19 0.6× 12 323
Gisela Schott Germany 9 93 0.3× 64 0.7× 100 1.4× 158 4.0× 37 1.2× 27 399
Gisbert Selke Germany 10 202 0.7× 68 0.8× 44 0.6× 19 0.5× 40 1.3× 20 765
Kathryn Teng United States 10 42 0.1× 82 1.0× 76 1.1× 71 1.8× 14 0.4× 25 336

Countries citing papers authored by Ott Laius

Since Specialization
Citations

This map shows the geographic impact of Ott Laius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ott Laius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ott Laius more than expected).

Fields of papers citing papers by Ott Laius

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ott Laius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ott Laius. The network helps show where Ott Laius may publish in the future.

Co-authorship network of co-authors of Ott Laius

This figure shows the co-authorship network connecting the top 25 collaborators of Ott Laius. A scholar is included among the top collaborators of Ott Laius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ott Laius. Ott Laius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Timonen, Johanna, et al.. (2024). Prescribing beyond borders: Navigating challenges and opportunities in cross-border ePrescriptions for enhanced medication access and safety. Research in Social and Administrative Pharmacy. 21(3). 178–184.
2.
Laius, Ott, et al.. (2023). Outpatient fluoroquinolone use in relation to European Medicines Agency's recommendation: An Estonian nationwide drug utilization study. Pharmacoepidemiology and Drug Safety. 32(6). 643–650. 3 indexed citations
3.
4.
Timonen, Johanna, et al.. (2023). Implementation of European Cross-border Electronic Prescription and Electronic Dispensing Service: Cross-sectional Survey. Journal of Medical Internet Research. 25. e42453–e42453. 5 indexed citations
5.
Laius, Ott, et al.. (2021). Trends in the use of hormonal contraception in Estonia 2005–2019 and the risk of arterial and venous thromboembolism: a population-based study. The European Journal of Contraception & Reproductive Health Care. 26(5). 413–420. 4 indexed citations
6.
Rakitin, Aleksei, et al.. (2021). Pre-pregnancy counseling for women with epilepsy: Can we do better?. Epilepsy & Behavior. 125. 108404–108404. 2 indexed citations
7.
Oona, Marje, et al.. (2021). COMBINED METHOD FOR ASSESSMENT OF MEDICATION ADHERENCE - A PILOT STUDY OF OUTPATIENTS TREATED WITH STATINS. Acta Poloniae Pharmaceutica - Drug Research. 77(6). 921–928. 1 indexed citations
8.
9.
Uusküla, Anneli, et al.. (2020). Trends in opioid prescribing in Estonia (2011‐2017). Pharmacology Research & Perspectives. 8(2). e00577–e00577. 5 indexed citations
10.
Harro, Jaanus, Kaire Aadamsoo, Ott Laius, et al.. (2019). Comparison of psychotropic medication use in the Baltic countries. Nordic Journal of Psychiatry. 74(4). 301–306. 5 indexed citations
11.
Uusküla, Anneli, et al.. (2018). Compliance with Pregnancy Prevention Recommendations for Isotretinoin in Estonia in 2012–2016. Drugs - Real World Outcomes. 5(2). 129–136. 11 indexed citations
12.
Laius, Ott, Heti Pisarev, Daisy Volmer, et al.. (2017). Use of a national database as a tool to identify primary medication non-adherence: The Estonian ePrescription system. Research in Social and Administrative Pharmacy. 14(8). 776–783. 9 indexed citations
13.
Laius, Ott, Heti Pisarev, Katre Maasalu, Sulev Kõks, & Aare Märtson. (2017). Trends in and relation between hip fracture incidence and osteoporosis medication utilization and prices in Estonia in 2004–2015. Archives of Osteoporosis. 12(1). 48–48. 6 indexed citations
14.
Laius, Ott, Heti Pisarev, Katre Maasalu, Sulev Kõks, & Aare Märtson. (2017). Adherence to osteoporosis medicines in Estonia—a comprehensive 15-year retrospective prescriptions database study. Archives of Osteoporosis. 12(1). 59–59. 5 indexed citations
15.
Laius, Ott, Katre Maasalu, Sulev Kõks, & Aare Märtson. (2016). Use of drugs against osteoporosis in the Baltic countries during 2010–2014. Medicina. 52(5). 315–320. 4 indexed citations
16.
Maasalu, Katre, Ott Laius, Lidiia Zhytnik, et al.. (2016). Featured Article: Transcriptional landscape analysis identifies differently expressed genes involved in follicle-stimulating hormone induced postmenopausal osteoporosis. Experimental Biology and Medicine. 242(2). 203–213. 5 indexed citations
17.
Harrison, Pille, Ott Laius, & Alar Irs. (2014). Sarnased bioloogilised ravimid. Ajakirjad. Journals by UT. 1 indexed citations
18.
Harrison, Pille, Ott Laius, & Alar Irs. (2014). Sarnased bioloogilised ravimid – epoetiinid. Ajakirjad. Journals by UT.
19.
Godman, Brian, Björn Wettermark, Iain Bishop, et al.. (2012). European payer initiatives to reduce prescribing costs through use of generics. Generics and Biosimilars Initiative Journal. 1(1). 22–27. 37 indexed citations
20.
Godman, Brian, Harald Herholz, Ott Laius, et al.. (2010). Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers. BMC Health Services Research. 10(1). 153–153. 184 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roberta Joppi Breakdown of academic impact, for papers by Lisa A. Fulchino Breakdown of academic impact, for papers by Genia Long Breakdown of academic impact, for papers by Marija Kalaba Breakdown of academic impact, for papers by Niesha Griffith Breakdown of academic impact, for papers by Karen Van Nuys Breakdown of academic impact, for papers by Harald Herholz Breakdown of academic impact, for papers by Gisela Schott Breakdown of academic impact, for papers by Gisbert Selke Breakdown of academic impact, for papers by Kathryn Teng
Rankless by CCL
2026